Dave Puente; Frits van Rhee; chimeric antigen receptor; CAR T-Cell Therapy; Myeloma Center; Winthrop P. Rockefeller Cancer Institute; Chimeric antigen receptor (CAR) T-cell therapy; Frits van Rhee

June 17, 2022

Myeloma Patient Celebrates Full Remission by Walking Daughter Down the Aisle

Linda Haymes

“I was very pleased to be able to offer Dave this novel immunotherapy, which takes the patient’s own immune cells and genetically re-programs the cells to attack the myeloma,” Puente's doctor Frits van Rhee said. “I am very excited that Dave tolerated the treatment well and that he has had an excellent response to it.”

Dave Puente of Elk Grove California, the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) last November, recently saw a very personal goal he’d set for himself become a reality. Late last year, during an interview for an article…